| Clinical data | |
|---|---|
| Other names | Progesterone conjugate |
| Drug class | Progestogen; Neurosteroid |
| Identifiers | |
| CAS Number | |
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.
See also
- List of neurosteroids § Inhibitory > Synthetic > Pregnanes
- List of progestogen esters § Oximes of progesterone derivatives
- List of investigational sex-hormonal agents § Progestogenics
References
- ^ "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.
External links
 | This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |
 | This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |